Purchase Order 75N91021P00809

Award Date 9/7/21
Potential Completion Date 9/6/25
Potential Value $1.2M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cincinnati, OH 45236, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a sole-source federal contract awarded by the Department of Health and Human Services (HHS) National Cancer Institute (NCI) to Unlimited Technology Systems LLC, a for-profit limited liability company. The $225,160.03 firm-fixed-price contract is for the electronic capture of cancer claims data to support the NCI's Surveillance, Epidemiology, and End Results (SEER) Program. The contract requires Unlimited Technology Systems to provide weekly submissions of medical claims data from...
This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Unlimited Technology Systems LLC for $1,184,999.70. The contract is for support services related to cancer registry claims electronic data capture software support and installations. The contract has a base period of one year with the option to extend for up to an additional 12 months. It also includes options for onboarding new practices to the...
This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services, to Comstar Technology Institute LLC, a minority-owned small business, to provide services to enhance the functionalities of the SEERCMapper program and support its maintenance for 12 months. The total ceiling value of the contract is $29,940. The SEERCMapper is a standalone program that implements a class separability classification method...
This is a $17,528,318.00 delivery order contract awarded by the National Cancer Institute to the Department of Public Health Illinois, a state government entity, to provide core infrastructure support for the Surveillance Epidemiology and End Results (SEER) Program. The contract is part of a larger $500 million multiple-award Indefinite Delivery Vehicle (IDV) that supports the SEER Program, which collects and publishes cancer incidence and survival data from population-based cancer registries....
This is a delivery order under the Surveillance Epidemiology and End Results (SEER) Program, a multiple-award indefinite delivery contract with a potential ceiling value of $500 million that supports the expansion of population-based central cancer registries. The prime contractor is Rutgers, The State University of New Jersey, a major public research institution that has been awarded federal contracts and grants across numerous scientific domains. The contract has a ceiling value of...
<p>This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency, to Riessearch LLC, a woman-owned small business. The contract is for the development of recommendations for coding across cancer reporting systems for the Surveillance, Epidemiology, and End Results (SEER) program. The contract has a total ceiling value of $141,592 and a completion date of September 14, 2018. The contract does not have a set-aside designation.</p>
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Colleen Makin, doing business as Datawaves, a woman-owned small business. The contract is for the maintenance and enhancement of the SEERCMapper software, which supports choropleth mapping of SEER (Surveillance, Epidemiology, and End Results) cancer data. The contract has a potential value of $145,485.40 and a completion date of September...
This is a federal contract award to the University of Southern California (USC) by the National Cancer Institute (NCI), a civilian agency. The contract has a ceiling value of $43,591,028.83 and is a delivery order under the NCI's Surveillance Epidemiology and End Results (SEER) Program Indefinite Delivery Contract vehicle. The contract is not set aside for any specific business type. The contract is for &quot;CORE INFRASTRUCTURE&quot; services and supports the SEER Program, which is a major...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Cancer Prevention Institute of California. The contract, valued at $130,809.00, is for the Patterns of Care/Quality of Care Study for diagnosis year 2014 under the Surveillance, Epidemiology and End Results (SEER) program. The contract does not have a set-aside designation. The contract delivers products and services related to the SEER program, which is a major NCI program focused on...
<p>This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency, to Inspirata Canada Inc. The contract is for core and administrative maintenance and installation support for the Surveillance Epidemiology and End Results (SEER) electronic data capture software. The contract does not have a set-aside designation. The total ceiling value of the contract is $1,135,265.00 with a period of performance through September 25, 2016.</p>

This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Unlimited Technology Systems LLC for $1,233,181.56 to provide electronic capture of cancer claims data for the Surveillance, Epidemiology, and End Results (SEER) program. The contract has a base period of one year with four one-year option periods, for a potential total duration of 60 months.

The contract requires Unlimited Technology Systems to maintain the existing network of 448 oncology providers across 6 SEER areas and onboard up to 6 new practices per year to transmit weekly cancer claims data in the ANSI 837 format. This data will be used by SEER to rapidly identify new cancer cases, capture systemic therapy details, and ascertain patient follow-up information. The contract has no set-aside designation.

Generated 7/16/25, 12:30 PM